$LIEN
Chicago Atlantic BDC, Inc. Stock $lien

$lien Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000114036124025238 Filed on May 09, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$1.526M	-$79.81K	$1.371M
YoY Change	-19.68%	-105.82%	-735.97%
Cost Of Revenue	$611.9K	$379.9K	$669.9K
YoY Change	-16.54%	-43.29%
Gross Profit	$2.469M	$2.380M	$1.788M
YoY Change	14.3%	33.14%
Gross Profit Margin	161.86%		130.44%
Selling, General & Admin	$409.9K	$334.9K	$397.7K
YoY Change	8.28%	-15.78%
% of Gross Profit	16.6%	14.07%	22.24%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$410.8K	$354.1K	$417.2K
YoY Change	57.3%	-15.12%
Operating Profit	$2.059M	$2.026M	$1.371M
YoY Change	8.38%	47.82%
Interest Expense	-$232.8K	$599.6K	$986.4K
YoY Change	-66.17%	-39.21%
% of Operating Profit	-11.31%	29.59%	71.96%
Other Income/Expense, Net
YoY Change
Pretax Income	$1.293M	$519.8K	$2.357M
YoY Change	6.72%	-77.95%
Income Tax
% Of Pretax Income
Net Earnings	-$260.7K	-$1.034M	$2.357M
YoY Change	-121.52%	-143.86%	-97.23%
Net Earnings / Revenue	-17.09%		171.96%
Basic Earnings Per Share	$0.21	$0.08	$0.38
Diluted Earnings Per Share	$0.21	$0.08	$0.38
COMMON SHARES
Basic Shares Outstanding	6.215M	6.215M	6.215M
Diluted Shares Outstanding	6.215M	6.215M	6.215M

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$34.00M	$33.16M	$32.54M
YoY Change	3.37%	1.89%
Cash & Equivalents	$34.00M	$33.16M	$32.54M
Short-Term Investments
Other Short-Term Assets	$183.0K	$261.5K	$254.7K
YoY Change	1.83%	2.68%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$35.85M	$35.10M	$34.37M
YoY Change	6.48%	2.12%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$53.40M	$54.85M	$55.62M
YoY Change	-7.41%	-1.39%
Other Assets	$761.9K	$333.3K
YoY Change
Total Long-Term Assets	$54.23M	$55.25M	$55.62M
YoY Change	-5.96%	-0.66%
TOTAL ASSETS
Total Short-Term Assets	$35.85M	$35.10M	$34.37M
Total Long-Term Assets	$54.23M	$55.25M	$55.62M
Total Assets	$90.08M	$90.35M	$89.99M
YoY Change	-1.38%	0.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$195.4K	$216.9K
YoY Change
Accrued Expenses	$2.507M	$2.713M	$0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.756M	$5.832M	$1.157M
YoY Change	345.71%	404.01%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$62.19K
YoY Change
Total Long-Term Liabilities	$62.19K	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.756M	$5.832M	$1.157M
Total Long-Term Liabilities	$62.19K	$0.00	$0.00
Total Liabilities	$5.819M	$5.832M	$1.157M
YoY Change	350.53%	404.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$834.9K	-$574.0K	$3.732M
YoY Change	-116.89%	-115.38%
Common Stock	$62.15K	$62.15K	$62.15K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$84.26M	$84.52M	$88.83M
YoY Change
Total Liabilities & Shareholders Equity	$90.08M	$90.35M	$89.99M
YoY Change	-1.38%	0.4%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$260.7K	-$1.034M	$2.357M
YoY Change	-121.52%	-143.86%	-97.23%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$2.481M	$2.103M	-$2.581M
YoY Change	605.69%	-181.47%	407.02%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid			$0.00
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.638M	-1.554M	0.000
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	2.481M	2.103M	-2.581M
Cash From Investing Activities
Cash From Financing Activities	-1.638M	-1.554M	0.000
Net Change In Cash	843.6K	548.7K	-2.581M
YoY Change	139.9%	-121.26%	-103.05%
FREE CASH FLOW
Cash From Operating Activities	$2.481M	$2.103M	-$2.581M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33160294
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32611635
CY2024Q1	us-gaap	Interest Receivable InterestReceivable	1675075
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	1755360
CY2024Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	261473
CY2023Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	39276
CY2024Q1	us-gaap	Assets Assets	90351075
CY2023Q4	us-gaap	Assets Assets	88576271
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	62149
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	62149
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	85030601
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	85041203
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-573983
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	449266
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	84518767
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	85552618
CY2024Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	13.6
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	1370723
CY2024Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	519811
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	2357080
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6214941
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6214941
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6214672
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6214672
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	13.77
CY2023Q4	us-gaap	Other Assets OtherAssets	50000
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6214949
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6214949
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6214941
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	2357080
CY2024Q1	us-gaap	Unrealized Gain Loss Investment And Derivative Operating After Tax UnrealizedGainLossInvestmentAndDerivativeOperatingAfterTax	599620
CY2023Q1	us-gaap	Unrealized Gain Loss Investment And Derivative Operating After Tax UnrealizedGainLossInvestmentAndDerivativeOperatingAfterTax	986357
CY2024Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	-141429
CY2023Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	-140819
CY2024Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	0
CY2024Q1	ssic	Capitalized Paid In Kind Interest CapitalizedPaidInKindInterest	-52951
CY2023Q1	ssic	Capitalized Paid In Kind Interest CapitalizedPaidInKindInterest	-11573
CY2024Q1	ssic	Proceeds From Sale Of Investments And Principal Repayments ProceedsFromSaleOfInvestmentsAndPrincipalRepayments	63000
CY2023Q1	ssic	Proceeds From Sale Of Investments And Principal Repayments ProceedsFromSaleOfInvestmentsAndPrincipalRepayments	0
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2581293
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32611635
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35125320
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33160294
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32544027
CY2024Q1	ssic	Reinvestment Of Stockholder Distributions ReinvestmentOfStockholderDistributions	74
CY2023Q4	us-gaap	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap/2023#WestRegionMember
CY2023Q4	us-gaap	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap/2023#NortheastRegionMember
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001843162
CY2023	us-gaap	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20240331#ShryneGroupIncMember
CY2024Q1	us-gaap	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20240331#VeranoHoldingsCorpMember
CY2024Q1	us-gaap	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20240331#CuraleafHoldingsIncMember
CY2024Q1	us-gaap	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20240331#PharmaCannIncMember
CY2023	us-gaap	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20240331#VeranoHoldingsCorpMember
CY2024Q1	us-gaap	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20240331#ShryneGroupIncMember
CY2023	us-gaap	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20240331#DreamfieldsBrandsIncMember
CY2023	us-gaap	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20240331#PharmaCannIncMember
CY2023	us-gaap	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20240331#CuraleafHoldingsIncMember
CY2024Q1	us-gaap	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20240331#DreamfieldsBrandsIncMember
CY2023Q4	us-gaap	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20240331#SeniorSecuredFirstLienTermLoanMember
CY2024Q1	us-gaap	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20240331#SeniorSecuredFirstLienTermLoanMember
CY2024Q1	us-gaap	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20240331#SeniorSecuredFirstLienTermLoanMember
CY2023Q4	us-gaap	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20240331#SeniorSecuredNoteMember
CY2024Q1	us-gaap	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20240331#SeniorSecuredFirstLienTermLoanMember
CY2024Q1	us-gaap	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20240331#SeniorSecuredNoteMember
CY2023Q4	us-gaap	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20240331#SeniorSecuredFirstLienTermLoanMember
CY2023Q4	us-gaap	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20240331#SeniorSecuredFirstLienTermLoanMember
CY2023Q4	us-gaap	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20240331#SeniorSecuredNoteMember
CY2024Q1	us-gaap	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20240331#SeniorSecuredNoteMember
CY2023Q4	us-gaap	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2024Q1	us-gaap	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2024Q1	us-gaap	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2023Q4	us-gaap	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2024Q1	us-gaap	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2024Q1	us-gaap	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2023Q4	us-gaap	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2024Q1	us-gaap	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2023Q4	us-gaap	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2023Q4	us-gaap	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2023Q4	us-gaap	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap/2023#WestRegionMember
CY2023Q4	us-gaap	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap/2023#MidwestRegionMember
CY2024Q1	us-gaap	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap/2023#WestRegionMember
CY2024Q1	us-gaap	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap/2023#MidwestRegionMember
CY2023Q4	us-gaap	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap/2023#MidwestRegionMember
CY2024Q1	us-gaap	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap/2023#MidwestRegionMember
CY2024Q1	us-gaap	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap/2023#WestRegionMember
CY2024Q1	us-gaap	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap/2023#NortheastRegionMember
CY2024Q1	us-gaap	Investment Issuer Affiliation Extensible Enumeration InvestmentIssuerAffiliationExtensibleEnumeration	http://fasb.org/us-gaap/2023#InvestmentUnaffiliatedIssuerMember
CY2023Q4	us-gaap	Investment Issuer Affiliation Extensible Enumeration InvestmentIssuerAffiliationExtensibleEnumeration	http://fasb.org/us-gaap/2023#InvestmentUnaffiliatedIssuerMember
CY2024Q1	us-gaap	Debt Securities Fair Value By Fair Value Hierarchy Level Extensible List DebtSecuritiesFairValueByFairValueHierarchyLevelExtensibleList	http://fasb.org/us-gaap/2023#FairValueInputsLevel3Member
CY2024Q1	us-gaap	Debt Securities Fair Value By Fair Value Hierarchy Level Extensible List DebtSecuritiesFairValueByFairValueHierarchyLevelExtensibleList	http://fasb.org/us-gaap/2023#FairValueInputsLevel3Member
CY2024Q1	us-gaap	Debt Securities Fair Value By Fair Value Hierarchy Level Extensible List DebtSecuritiesFairValueByFairValueHierarchyLevelExtensibleList	http://fasb.org/us-gaap/2023#FairValueInputsLevel3Member
CY2024Q1	us-gaap	Debt Securities Fair Value By Fair Value Hierarchy Level Extensible List DebtSecuritiesFairValueByFairValueHierarchyLevelExtensibleList	http://fasb.org/us-gaap/2023#FairValueInputsLevel3Member
CY2024Q1	us-gaap	Debt Securities Fair Value By Fair Value Hierarchy Level Extensible List DebtSecuritiesFairValueByFairValueHierarchyLevelExtensibleList	http://fasb.org/us-gaap/2023#FairValueInputsLevel3Member
CY2024Q1	us-gaap	Debt Securities Fair Value By Fair Value Hierarchy Level Extensible List DebtSecuritiesFairValueByFairValueHierarchyLevelExtensibleList	http://fasb.org/us-gaap/2023#FairValueInputsLevel1Member
CY2023Q4	us-gaap	Debt Securities Fair Value By Fair Value Hierarchy Level Extensible List DebtSecuritiesFairValueByFairValueHierarchyLevelExtensibleList	http://fasb.org/us-gaap/2023#FairValueInputsLevel3Member
CY2023Q4	us-gaap	Debt Securities Fair Value By Fair Value Hierarchy Level Extensible List DebtSecuritiesFairValueByFairValueHierarchyLevelExtensibleList	http://fasb.org/us-gaap/2023#FairValueInputsLevel3Member
CY2023Q4	us-gaap	Debt Securities Fair Value By Fair Value Hierarchy Level Extensible List DebtSecuritiesFairValueByFairValueHierarchyLevelExtensibleList	http://fasb.org/us-gaap/2023#FairValueInputsLevel3Member
CY2023Q4	us-gaap	Debt Securities Fair Value By Fair Value Hierarchy Level Extensible List DebtSecuritiesFairValueByFairValueHierarchyLevelExtensibleList	http://fasb.org/us-gaap/2023#FairValueInputsLevel3Member
CY2023Q4	us-gaap	Debt Securities Fair Value By Fair Value Hierarchy Level Extensible List DebtSecuritiesFairValueByFairValueHierarchyLevelExtensibleList	http://fasb.org/us-gaap/2023#FairValueInputsLevel3Member
CY2023Q4	us-gaap	Debt Securities Fair Value By Fair Value Hierarchy Level Extensible List DebtSecuritiesFairValueByFairValueHierarchyLevelExtensibleList	http://fasb.org/us-gaap/2023#FairValueInputsLevel1Member
CY2024Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	333320
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	0
CY2024Q1	us-gaap	Other Assets OtherAssets	69913
CY2024Q1	ssic	Transaction Fees Payable Current And Noncurrent TransactionFeesPayableCurrentAndNoncurrent	2712577
CY2023Q4	ssic	Transaction Fees Payable Current And Noncurrent TransactionFeesPayableCurrentAndNoncurrent	711264
CY2024Q1	ssic	Income Based Incentive Fee Payable IncomeBasedIncentiveFeePayable	1511253
CY2023Q4	ssic	Income Based Incentive Fee Payable IncomeBasedIncentiveFeePayable	1511253
CY2024Q1	ssic	Due To Custodian Current And Noncurrent DueToCustodianCurrentAndNoncurrent	468829
CY2023Q4	ssic	Due To Custodian Current And Noncurrent DueToCustodianCurrentAndNoncurrent	0
CY2024Q1	ssic	Offering Costs Payable OfferingCostsPayable	332564
CY2023Q4	ssic	Offering Costs Payable OfferingCostsPayable	0
CY2024Q1	us-gaap	Management Fee Payable ManagementFeePayable	246131
CY2023Q4	us-gaap	Management Fee Payable ManagementFeePayable	257121
CY2024Q1	ssic	Capital Gains Incentive Fee Payable CapitalGainsIncentiveFeePayable	207507
CY2023Q1	ssic	Income Based Incentive Fee Expense IncomeBasedIncentiveFeeExpense	203821
CY2023Q4	ssic	Capital Gains Incentive Fee Payable CapitalGainsIncentiveFeePayable	87583
CY2024Q1	ssic	Audit Fees Payable Current And Noncurrent AuditFeesPayableCurrentAndNoncurrent	136623
CY2023Q4	ssic	Audit Fees Payable Current And Noncurrent AuditFeesPayableCurrentAndNoncurrent	123998
CY2024Q1	ssic	Administrator Fees Payable Current And Noncurrent AdministratorFeesPayableCurrentAndNoncurrent	107075
CY2023Q4	ssic	Administrator Fees Payable Current And Noncurrent AdministratorFeesPayableCurrentAndNoncurrent	86463
CY2024Q1	ssic	Legal Fees Payable Current And Noncurrent LegalFeesPayableCurrentAndNoncurrent	71660
CY2023Q4	ssic	Legal Fees Payable Current And Noncurrent LegalFeesPayableCurrentAndNoncurrent	84824
CY2024Q1	us-gaap	Other Liabilities OtherLiabilities	16676
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	13822
CY2024Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	11750
CY2023Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	17233
CY2024Q1	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	9405
CY2023Q4	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	24675
CY2024Q1	ssic	Directors Fee Payable Current And Noncurrent DirectorsFeePayableCurrentAndNoncurrent	258
CY2023Q4	ssic	Directors Fee Payable Current And Noncurrent DirectorsFeePayableCurrentAndNoncurrent	94760
CY2024Q1	ssic	Liquidating Distributions Payable LiquidatingDistributionsPayable	0
CY2023Q4	ssic	Liquidating Distributions Payable LiquidatingDistributionsPayable	2
CY2024Q1	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	0
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	10655
CY2024Q1	us-gaap	Liabilities Liabilities	5832308
CY2023Q4	us-gaap	Liabilities Liabilities	3023653
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6214941
CY2024Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2106050
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0
CY2024Q1	us-gaap	Management Fee Expense ManagementFeeExpense	246131
CY2023Q1	us-gaap	Management Fee Expense ManagementFeeExpense	238419
CY2024Q1	ssic	Capital Gains Incentive Fee Expense CapitalGainsIncentiveFeeExpense	119924
CY2023Q1	ssic	Capital Gains Incentive Fee Expense CapitalGainsIncentiveFeeExpense	142602
CY2024Q1	ssic	Audit Fee Expense AuditFeeExpense	106625
CY2023Q1	ssic	Audit Fee Expense AuditFeeExpense	97883
CY2024Q1	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	98456
CY2023Q1	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	77844
CY2024Q1	us-gaap	General Insurance Expense GeneralInsuranceExpense	66279
CY2023Q1	us-gaap	General Insurance Expense GeneralInsuranceExpense	69082
CY2024Q1	us-gaap	Legal Fees LegalFees	58051
CY2023Q1	us-gaap	Legal Fees LegalFees	98760
CY2024Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	19191
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	19504
CY2024Q1	us-gaap	Custody Fees CustodyFees	11850
CY2023Q1	us-gaap	Custody Fees CustodyFees	12000
CY2024Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	5526
CY2023Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	35944
CY2024Q1	ssic	Valuation Fees Expense ValuationFeesExpense	1973
CY2023Q1	ssic	Valuation Fees Expense ValuationFeesExpense	73065
CY2024Q1	ssic	Income Based Incentive Fee Expense IncomeBasedIncentiveFeeExpense	0
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	0
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	18192
CY2024Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	2840056
CY2023Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	1087116
CY2024Q1	us-gaap	Net Investment Income NetInvestmentIncome	-79809
CY2024Q1	us-gaap	Realized Gain Loss Investment And Derivative Operating After Tax RealizedGainLossInvestmentAndDerivativeOperatingAfterTax	0
CY2023Q1	us-gaap	Realized Gain Loss Investment And Derivative Operating After Tax RealizedGainLossInvestmentAndDerivativeOperatingAfterTax	0
CY2024Q1	us-gaap	Unrealized Gain Loss Investment And Derivative Operating After Tax UnrealizedGainLossInvestmentAndDerivativeOperatingAfterTax	599620
CY2023Q1	us-gaap	Unrealized Gain Loss Investment And Derivative Operating After Tax UnrealizedGainLossInvestmentAndDerivativeOperatingAfterTax	986357
CY2024Q1	ssic	Net Realized And Unrealized Gains Losses NetRealizedAndUnrealizedGainsLosses	599620
CY2023Q1	ssic	Net Realized And Unrealized Gains Losses NetRealizedAndUnrealizedGainsLosses	986357
CY2024Q1	ssic	Net Investment Income Loss Per Share Diluted NetInvestmentIncomeLossPerShareDiluted	-0.01
CY2024Q1	ssic	Net Investment Income Loss Per Share Basic NetInvestmentIncomeLossPerShareBasic	-0.01
CY2023Q1	ssic	Net Investment Income Loss Per Share Basic NetInvestmentIncomeLossPerShareBasic	0.22
CY2023Q1	ssic	Net Investment Income Loss Per Share Diluted NetInvestmentIncomeLossPerShareDiluted	0.22
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.38
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	85552618
CY2024Q1	us-gaap	Net Investment Income NetInvestmentIncome	-79809
CY2024Q1	us-gaap	Realized Gain Loss Investment And Derivative Operating After Tax RealizedGainLossInvestmentAndDerivativeOperatingAfterTax	0
CY2024Q1	us-gaap	Unrealized Gain Loss Investment And Derivative Operating After Tax UnrealizedGainLossInvestmentAndDerivativeOperatingAfterTax	599620
CY2024Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	519811
CY2024Q1	us-gaap	Investment Income Net InvestmentIncomeNet	-1553736
CY2024Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	74
CY2024Q1	ssic	Stockholders Equity Increase Decrease In Net Assets From Capital Transactions StockholdersEquityIncreaseDecreaseInNetAssetsFromCapitalTransactions	74
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1033851
CY2024Q1	ssic	Capital Effect Of Permanent Adjustments CapitalEffectOfPermanentAdjustments	0
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	84518767
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	86475729
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	1370723
CY2023Q1	us-gaap	Realized Gain Loss Investment And Derivative Operating After Tax RealizedGainLossInvestmentAndDerivativeOperatingAfterTax	0
CY2023Q1	us-gaap	Unrealized Gain Loss Investment And Derivative Operating After Tax UnrealizedGainLossInvestmentAndDerivativeOperatingAfterTax	986357
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	2357080
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2357080
CY2023Q1	ssic	Capital Effect Of Permanent Adjustments CapitalEffectOfPermanentAdjustments	0
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	88832809
CY2024Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	519811
CY2023Q1	us-gaap	Payments For Purchase Of Securities Operating Activities PaymentsForPurchaseOfSecuritiesOperatingActivities	4230000
CY2024Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-80285
CY2023Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	8945
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	19913
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	222197
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	222328
CY2024Q1	ssic	Increase Decrease In Income Based Incentive Fee Payable IncreaseDecreaseInIncomeBasedIncentiveFeePayable	0
CY2023Q1	ssic	Increase Decrease In Income Based Incentive Fee Payable IncreaseDecreaseInIncomeBasedIncentiveFeePayable	203821
CY2024Q1	ssic	Increase Decrease In Management Fee Payables IncreaseDecreaseInManagementFeePayables	-10990
CY2023Q1	ssic	Increase Decrease In Management Fee Payables IncreaseDecreaseInManagementFeePayables	238419
CY2024Q1	ssic	Increase Decrease In Capital Gains Incentive Fee Payable IncreaseDecreaseInCapitalGainsIncentiveFeePayable	119924
CY2023Q1	ssic	Increase Decrease In Capital Gains Incentive Fee Payable IncreaseDecreaseInCapitalGainsIncentiveFeePayable	142602
CY2024Q1	ssic	Increase Decrease In Legal Fees Payable IncreaseDecreaseInLegalFeesPayable	-13164
CY2023Q1	ssic	Increase Decrease In Legal Fees Payable IncreaseDecreaseInLegalFeesPayable	57773
CY2024Q1	ssic	Increase Decrease In Transaction Fees Payable IncreaseDecreaseInTransactionFeesPayable	2001313
CY2023Q1	ssic	Increase Decrease In Transaction Fees Payable IncreaseDecreaseInTransactionFeesPayable	0
CY2024Q1	ssic	Increase Decrease In Valuation Fees Payables IncreaseDecreaseInValuationFeesPayables	-15270
CY2023Q1	ssic	Increase Decrease In Valuation Fees Payables IncreaseDecreaseInValuationFeesPayables	72185
CY2024Q1	ssic	Increase Decrease In Administrator Fees Payable IncreaseDecreaseInAdministratorFeesPayable	20612
CY2023Q1	ssic	Increase Decrease In Administrator Fees Payable IncreaseDecreaseInAdministratorFeesPayable	25630
CY2024Q1	ssic	Increase Decrease In Audit Fees Payable IncreaseDecreaseInAuditFeesPayable	12625
CY2023Q1	ssic	Increase Decrease In Audit Fees Payable IncreaseDecreaseInAuditFeesPayable	-2117
CY2024Q1	ssic	Increase Decrease In Director S Fee Payable IncreaseDecreaseInDirectorSFeePayable	-94502
CY2023Q1	ssic	Increase Decrease In Director S Fee Payable IncreaseDecreaseInDirectorSFeePayable	3895
CY2024Q1	ssic	Increase Decrease In Professional Fees Payable IncreaseDecreaseInProfessionalFeesPayable	-5483
CY2023Q1	ssic	Increase Decrease In Professional Fees Payable IncreaseDecreaseInProfessionalFeesPayable	18192
CY2024Q1	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	2854
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-18148
CY2024Q1	ssic	Increase Decrease In Due To Custodian Payable IncreaseDecreaseInDueToCustodianPayable	468829
CY2023Q1	ssic	Increase Decrease In Due To Custodian Payable IncreaseDecreaseInDueToCustodianPayable	0
CY2024Q1	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	0
CY2023Q1	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	-37
CY2024Q1	ssic	Increase Decrease In Excise Tax Payable IncreaseDecreaseInExciseTaxPayable	-10655
CY2023Q1	ssic	Increase Decrease In Excise Tax Payable IncreaseDecreaseInExciseTaxPayable	-80566
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2103079
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2581293
CY2024Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	756
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1553664
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1554420
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	548659
CY2023Q1	ssic	Reinvestment Of Stockholder Distributions ReinvestmentOfStockholderDistributions	0
CY2024Q1	us-gaap	Investment Acquisition Date InvestmentAcquisitionDate	2022-10-11
CY2024Q1	us-gaap	Investment Maturity Date InvestmentMaturityDate	2026-12-15
CY2024Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.08
CY2024Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	4500000
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	4026000
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	4208000
CY2024Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.0498
CY2024Q1	us-gaap	Investment Acquisition Date InvestmentAcquisitionDate	2023-05-03
CY2024Q1	us-gaap	Investment Maturity Date InvestmentMaturityDate	2026-05-03
CY2024Q1	us-gaap	Investment Basis Spread Variable Rate InvestmentBasisSpreadVariableRate	0.0875
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	33160000
CY2024Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.3923
CY2024Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.3923
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	33160000
CY2024Q1	us-gaap	Investment Interest Rate Floor InvestmentInterestRateFloor	0.075
CY2024Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	4320000
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	4237000
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	4320000
CY2024Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.0511
CY2024Q1	us-gaap	Investment Acquisition Date InvestmentAcquisitionDate	2022-06-30
CY2024Q1	us-gaap	Investment Maturity Date InvestmentMaturityDate	2025-06-30
CY2024Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.12
CY2024Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	4250000
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	4131000
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	4016000
CY2024Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.0475
CY2024Q1	us-gaap	Investment Acquisition Date InvestmentAcquisitionDate	2022-05-26
CY2024Q1	us-gaap	Investment Maturity Date InvestmentMaturityDate	2026-05-26
CY2024Q1	us-gaap	Investment Basis Spread Variable Rate InvestmentBasisSpreadVariableRate	0.085
CY2024Q1	us-gaap	Investment Interest Rate Floor InvestmentInterestRateFloor	0.04
CY2024Q1	ssic	Paid In Kind Interest Rate PaidInKindInterestRate	0.01
CY2024Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	21118000
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	20774000
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	21224000
CY2024Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.2511
CY2024Q1	us-gaap	Investment Acquisition Date InvestmentAcquisitionDate	2022-10-27
CY2024Q1	us-gaap	Investment Maturity Date InvestmentMaturityDate	2026-10-30
CY2024Q1	us-gaap	Investment Basis Spread Variable Rate InvestmentBasisSpreadVariableRate	0.065
CY2024Q1	us-gaap	Investment Interest Rate Floor InvestmentInterestRateFloor	0.0625
CY2024Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	20874000
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	20435000
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	21083000
CY2024Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.2495
CY2024Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	55062000
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	53603000
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	54851000
CY2024Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.649
CY2024Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.649
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	53603000
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	54851000
CY2024Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.649
CY2024Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.649
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	53603000
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	54851000
CY2024Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.649
CY2024Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.649
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	53603000
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	54851000
CY2024Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.649
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	33160000
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	33160000
CY2024Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.3923
CY2024Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1.0413
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	86763000
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	88011000
CY2024Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1.0413
CY2024Q1	us-gaap	Securities Held As Collateral At Fair Value SecuritiesHeldAsCollateralAtFairValue	25291000
CY2024Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.28
CY2024Q1	ssic	Prime Rate PrimeRate	0.085
CY2024Q1	ssic	Annualized Period Of Yield AnnualizedPeriodOfYield	P7D
CY2024Q1	ssic	Percentage Of Yield PercentageOfYield	0.0526
CY2023	us-gaap	Investment Acquisition Date InvestmentAcquisitionDate	2022-10-11
CY2023Q4	us-gaap	Investment Maturity Date InvestmentMaturityDate	2026-12-15
CY2023Q4	us-gaap	Investment Interest Rate InvestmentInterestRate	0.08
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	4500000
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	3989000
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	4140000
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.0484
CY2023	us-gaap	Investment Acquisition Date InvestmentAcquisitionDate	2023-05-03
CY2023Q4	us-gaap	Investment Maturity Date InvestmentMaturityDate	2026-05-03
CY2023Q4	us-gaap	Investment Basis Spread Variable Rate InvestmentBasisSpreadVariableRate	0.0875
CY2023Q4	us-gaap	Investment Interest Rate Floor InvestmentInterestRateFloor	0.075
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	4320000
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	4229000
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	4320000
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.0505
CY2023	us-gaap	Investment Acquisition Date InvestmentAcquisitionDate	2022-06-30
CY2023Q4	us-gaap	Investment Maturity Date InvestmentMaturityDate	2025-06-30
CY2023Q4	us-gaap	Investment Interest Rate InvestmentInterestRate	0.12
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	4250000
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	4109000
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	3974000
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.0465
CY2023	us-gaap	Investment Acquisition Date InvestmentAcquisitionDate	2022-05-26
CY2023Q4	us-gaap	Investment Maturity Date InvestmentMaturityDate	2026-05-26
CY2023Q4	us-gaap	Investment Basis Spread Variable Rate InvestmentBasisSpreadVariableRate	0.085
CY2023Q4	us-gaap	Investment Interest Rate Floor InvestmentInterestRateFloor	0.04
CY2023Q4	ssic	Paid In Kind Interest Rate PaidInKindInterestRate	0.01
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	21065000
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	20682000
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	20749000
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.2425
CY2023	us-gaap	Investment Acquisition Date InvestmentAcquisitionDate	2022-10-27
CY2023Q4	us-gaap	Investment Maturity Date InvestmentMaturityDate	2026-10-30
CY2023Q4	us-gaap	Investment Basis Spread Variable Rate InvestmentBasisSpreadVariableRate	0.065
CY2023Q4	us-gaap	Investment Interest Rate Floor InvestmentInterestRateFloor	0.0625
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	20937000
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	20462000
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	20937000
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.2447
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	55072000
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	53471000
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	54120000
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.6326
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.6326
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	53471000
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	54120000
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.6326
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.6326
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	53471000
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	54120000
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.6326
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.6326
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	53471000
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	54120000
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.6326
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	32612000
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	32612000
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.3812
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.3812
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	32612000
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	32612000
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.3812
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1.0138
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	86083000
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	86732000
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1.0138
CY2023Q4	us-gaap	Securities Held As Collateral At Fair Value SecuritiesHeldAsCollateralAtFairValue	25077000
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.293
CY2023Q4	ssic	Prime Rate PrimeRate	0.085
CY2023	ssic	Annualized Period Of Yield AnnualizedPeriodOfYield	P7D
CY2023Q4	ssic	Percentage Of Yield PercentageOfYield	0.0532
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33160000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32610000
CY2023Q4	us-gaap	Fair Value Option Loans Held As Assets Aggregate Amount In Nonaccrual Status FairValueOptionLoansHeldAsAssetsAggregateAmountInNonaccrualStatus	0
CY2024Q1	us-gaap	Fair Value Option Loans Held As Assets Aggregate Amount In Nonaccrual Status FairValueOptionLoansHeldAsAssetsAggregateAmountInNonaccrualStatus	0
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2585068
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2317020
CY2024Q1	us-gaap	Interest Receivable InterestReceivable	1675075
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	1755360
CY2024Q1	us-gaap	Fee Income FeeIncome	33750
CY2023Q1	us-gaap	Fee Income FeeIncome	0
CY2024Q1	ssic	Minimum Percentage Of Ordinary Income MinimumPercentageOfOrdinaryIncome	0.98
CY2024Q1	ssic	Minimum Percentage Of Capital Gains MinimumPercentageOfCapitalGains	0.982
CY2024Q1	ssic	Percentage Of Taxable Income And Gain Distributed By Company PercentageOfTaxableIncomeAndGainDistributedByCompany	0.90
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.04
CY2024Q1	ssic	Excise Tax Expense ExciseTaxExpense	0
CY2023Q1	ssic	Excise Tax Expense ExciseTaxExpense	0
CY2024Q1	ssic	Overpaid Excise Taxes OverpaidExciseTaxes	19913
CY2023Q4	ssic	Overpaid Excise Taxes OverpaidExciseTaxes	0
CY2024Q1	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	0
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	10655
CY2023	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0
CY2024Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0
CY2024Q1	ssic	Organizational Costs Payable Current And Noncurrent OrganizationalCostsPayableCurrentAndNoncurrent	0
CY2023Q4	ssic	Organizational Costs Payable Current And Noncurrent OrganizationalCostsPayableCurrentAndNoncurrent	0
CY2024Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	333320
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	0
CY2023Q1	ssic	Offering Costs Charged To Capital OfferingCostsChargedToCapital	0
CY2024Q1	ssic	Offering Costs Charged To Capital OfferingCostsChargedToCapital	0
CY2024Q1	ssic	Offering Cost Payable Current And Noncurrent OfferingCostPayableCurrentAndNoncurrent	332564
CY2023Q4	ssic	Offering Cost Payable Current And Noncurrent OfferingCostPayableCurrentAndNoncurrent	0
CY2024Q1	ssic	Percent Of Portfolio That Is Variable Rate PercentOfPortfolioThatIsVariableRate	0.848
CY2024Q1	ssic	Percent Of Portfolio That Is Fixed Rate PercentOfPortfolioThatIsFixedRate	0.152
CY2023Q4	ssic	Percent Of Portfolio That Is Variable Rate PercentOfPortfolioThatIsVariableRate	0.849
CY2023Q4	ssic	Percent Of Portfolio That Is Fixed Rate PercentOfPortfolioThatIsFixedRate	0.151
CY2023Q4	us-gaap	Derivative Number Of Instruments Held DerivativeNumberOfInstrumentsHeld	0
CY2024Q1	us-gaap	Derivative Number Of Instruments Held DerivativeNumberOfInstrumentsHeld	0
CY2024Q1	ssic	Investment Owned Loan Repayment Period InvestmentOwnedLoanRepaymentPeriod	P3Y
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	53602697
CY2024Q1	ssic	Investment Owned At Cost Percentage InvestmentOwnedAtCostPercentage	1
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	54851000
CY2024Q1	ssic	Equity Securities Fair Value Percentage EquitySecuritiesFairValuePercentage	1
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	53471317
CY2023Q4	ssic	Investment Owned At Cost Percentage InvestmentOwnedAtCostPercentage	1
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	54120000
CY2023Q4	ssic	Equity Securities Fair Value Percentage EquitySecuritiesFairValuePercentage	1
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	53602697
CY2024Q1	ssic	Investment Owned At Cost Percentage InvestmentOwnedAtCostPercentage	1
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	54851000
CY2024Q1	ssic	Equity Securities Fair Value Percentage EquitySecuritiesFairValuePercentage	1
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	53471317
CY2023Q4	ssic	Investment Owned At Cost Percentage InvestmentOwnedAtCostPercentage	1
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	54120000
CY2023Q4	ssic	Equity Securities Fair Value Percentage EquitySecuritiesFairValuePercentage	1
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	53602697
CY2024Q1	ssic	Investment Owned At Cost Percentage InvestmentOwnedAtCostPercentage	1
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	54851000
CY2024Q1	ssic	Equity Securities Fair Value Percentage EquitySecuritiesFairValuePercentage	1
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	53471317
CY2023Q4	ssic	Investment Owned At Cost Percentage InvestmentOwnedAtCostPercentage	1
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	54120000
CY2023Q4	ssic	Equity Securities Fair Value Percentage EquitySecuritiesFairValuePercentage	1
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	54851000
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	54120000
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	54120000
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	0
CY2024Q1	ssic	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Accretion Of Discount And Fees Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAndFeesNet	141429
CY2024Q1	ssic	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Paid In Kind Interest Investment FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPaidInKindInterestInvestment	52951
CY2024Q1	ssic	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Proceeds From Sale Of Investments And Principal Repayments FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetProceedsFromSaleOfInvestmentsAndPrincipalRepayments	63000
CY2024Q1	ssic	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Net Realized Gain Loss On Investments FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetNetRealizedGainLossOnInvestments	0
CY2024Q1	ssic	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Net Change In Unrealized Appreciation Or Depreciation From Investments FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNetChangeInUnrealizedAppreciationOrDepreciationFromInvestments	599620
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	54851000
CY2024Q1	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	599620
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	50254550
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	4230000
CY2023Q1	ssic	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Accretion Of Discount And Fees Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAndFeesNet	140819
CY2023Q1	ssic	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Paid In Kind Interest Investment FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPaidInKindInterestInvestment	11573
CY2023Q1	ssic	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Proceeds From Sale Of Investments And Principal Repayments FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetProceedsFromSaleOfInvestmentsAndPrincipalRepayments	0
CY2023Q1	ssic	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Net Realized Gain Loss On Investments FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetNetRealizedGainLossOnInvestments	0
CY2023Q1	ssic	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Net Change In Unrealized Appreciation Or Depreciation From Investments FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNetChangeInUnrealizedAppreciationOrDepreciationFromInvestments	986357
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	55623299
CY2023Q1	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	986357
CY2024Q1	us-gaap	Management Fee Expense ManagementFeeExpense	246131
CY2023Q1	us-gaap	Management Fee Expense ManagementFeeExpense	238419
CY2024Q1	us-gaap	Management Fee Payable ManagementFeePayable	246131
CY2023Q4	us-gaap	Management Fee Payable ManagementFeePayable	257121
CY2024Q1	ssic	Income Based Incentive Fee Expense IncomeBasedIncentiveFeeExpense	0
CY2023Q1	ssic	Income Based Incentive Fee Expense IncomeBasedIncentiveFeeExpense	203821
CY2024Q1	ssic	Income Based Incentive Fee Payable IncomeBasedIncentiveFeePayable	1511253
CY2023Q4	ssic	Income Based Incentive Fee Payable IncomeBasedIncentiveFeePayable	1511253
CY2024Q1	ssic	Capital Gains Incentive Fee Expense CapitalGainsIncentiveFeeExpense	119924
CY2023Q1	ssic	Capital Gains Incentive Fee Expense CapitalGainsIncentiveFeeExpense	142602
CY2024Q1	ssic	Capital Gains Incentive Fee Payable CapitalGainsIncentiveFeePayable	207507
CY2023Q4	ssic	Capital Gains Incentive Fee Payable CapitalGainsIncentiveFeePayable	87583
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	386
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5400
CY2024Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	519811
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	2357080
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6214941
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6214941
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6214672
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6214672
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.38
CY2024Q1	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	210767
CY2024	us-gaap	Investment Company Distribution Ordinary Income InvestmentCompanyDistributionOrdinaryIncome	9819273
CY2023	us-gaap	Investment Company Distribution Ordinary Income InvestmentCompanyDistributionOrdinaryIncome	0
CY2024	us-gaap	Investment Company Distribution Long Term Capital Gain InvestmentCompanyDistributionLongTermCapitalGain	0
CY2023	us-gaap	Investment Company Distribution Long Term Capital Gain InvestmentCompanyDistributionLongTermCapitalGain	0
CY2024	us-gaap	Investment Company Tax Return Of Capital Distribution InvestmentCompanyTaxReturnOfCapitalDistribution	0
CY2023	us-gaap	Investment Company Tax Return Of Capital Distribution InvestmentCompanyTaxReturnOfCapitalDistribution	0
CY2024	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	9819273
CY2023	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	0
CY2024Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	1782017
CY2023Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	3418714
CY2024Q1	us-gaap	Tax Basis Of Investments Unrealized Appreciation Depreciation Net TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet	1248303
CY2023Q1	us-gaap	Tax Basis Of Investments Unrealized Appreciation Depreciation Net TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet	713009
CY2024Q1	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	210767
CY2023Q1	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	0
CY2024Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	3393536
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-399948
CY2024Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	573983
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3731775
CY2024Q1	us-gaap	Tax Basis Of Investments Cost For Income Tax Purposes TaxBasisOfInvestmentsCostForIncomeTaxPurposes	86762991
CY2023Q4	us-gaap	Tax Basis Of Investments Cost For Income Tax Purposes TaxBasisOfInvestmentsCostForIncomeTaxPurposes	86082952
CY2024Q1	us-gaap	Tax Basis Of Investments Gross Unrealized Appreciation TaxBasisOfInvestmentsGrossUnrealizedAppreciation	1363524
CY2023Q4	us-gaap	Tax Basis Of Investments Gross Unrealized Appreciation TaxBasisOfInvestmentsGrossUnrealizedAppreciation	784052
CY2024Q1	us-gaap	Tax Basis Of Investments Gross Unrealized Depreciation TaxBasisOfInvestmentsGrossUnrealizedDepreciation	115221
CY2023Q4	us-gaap	Tax Basis Of Investments Gross Unrealized Depreciation TaxBasisOfInvestmentsGrossUnrealizedDepreciation	135369
CY2024Q1	us-gaap	Tax Basis Of Investments Unrealized Appreciation Depreciation Net TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet	1248303
CY2023Q4	us-gaap	Tax Basis Of Investments Unrealized Appreciation Depreciation Net TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet	648683
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	13.77
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	13.91
CY2024Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	-0.01
CY2023Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.22
CY2024Q1	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.09
CY2023Q1	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.16
CY2024Q1	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.08
CY2023Q1	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.38
CY2024Q1	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.25
CY2023Q1	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0
CY2024Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	13.6
CY2023Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	14.29
CY2024Q1	us-gaap	Assets Net AssetsNet	84518767
CY2023Q1	us-gaap	Assets Net AssetsNet	88832809
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6214949
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6214672
CY2024Q1	ssic	Weighted Average Net Assets WeightedAverageNetAssets	85541257
CY2023Q1	ssic	Weighted Average Net Assets WeightedAverageNetAssets	86501919
CY2024Q1	ssic	Per Share Market Value PerShareMarketValue	9.61
CY2023Q1	ssic	Per Share Market Value PerShareMarketValue	9.19
CY2024Q1	ssic	Investment Company Total Return On Market Value InvestmentCompanyTotalReturnOnMarketValue	0.1682
CY2023Q1	ssic	Investment Company Total Return On Market Value InvestmentCompanyTotalReturnOnMarketValue	-0.0622
CY2024Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0133
CY2023Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0273
CY2024Q1	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.0332
CY2023Q1	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.0126
CY2024Q1	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	-0.0009
CY2023Q1	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.0158
CY2024Q1	ssic	Investment Company Portfolio Turnover Ratio InvestmentCompanyPortfolioTurnoverRatio	0.001
CY2023Q4	ssic	Number Of Loans In Portfolio NumberOfLoansInPortfolio	24
CY2023Q4	ssic	Loans In Portfolio Principal Outstanding LoansInPortfolioPrincipalOutstanding	130000000
CY2023Q4	ssic	Number Of Loans To Be Acquired NumberOfLoansToBeAcquired	4
CY2023Q4	ssic	Principal Amount Of Loans To Be Acquired PrincipalAmountOfLoansToBeAcquired	43000000
CY2024Q1	ssic	Termination Fee TerminationFee	6046613
CY2024Q1	ssic	Indemnification Quotient IndemnificationQuotient	10000000
CY2024Q1	ssic	Percent Of Outstanding Shares After Giving Effect To The Stock Issuance PercentOfOutstandingSharesAfterGivingEffectToTheStockIssuance	0.03
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
0001140361-24-025238-index-headers.html	Edgar Link	pending
0001140361-24-025238-index.html	Edgar Link	pending
0001140361-24-025238.txt	Edgar Link	pending
0001140361-24-025238-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ef20026306_10q.htm	Edgar Link	pending
ef20026306_ex31-1.htm	Edgar Link	pending
ef20026306_ex31-2.htm	Edgar Link	pending
ef20026306_ex32-1.htm	Edgar Link	pending
ef20026306_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
ef20026306_10q_htm.xml	Edgar Link	completed
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ssic-20240331.xsd	Edgar Link	pending
ssic-20240331_cal.xml	Edgar Link	unprocessable
ssic-20240331_def.xml	Edgar Link	unprocessable
ssic-20240331_lab.xml	Edgar Link	unprocessable
ssic-20240331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LIEN
Chicago Atlantic BDC, Inc. Stock $lien

2024 Q2 Form 10-Q Financial Statement

#000114036124025238 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LIEN Chicago Atlantic BDC, Inc. Stock $lien

2024 Q2 Form 10-Q Financial Statement

#000114036124025238 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LIEN
Chicago Atlantic BDC, Inc. Stock $lien